0P0001F59D - Candriam Equities L Oncology Impact R2 USD Cap

Other OTC - Other OTC Delayed Price. Currency in USD
140.04
-3.55 (-2.47%)
At close: 04:00PM EDT
Stock chart is not supported by your current browser
Previous Close143.59
YTD ReturnN/A
Expense Ratio (net)0.00%
CategoryN/A
Last Cap GainN/A
Morningstar Rating★★★★★
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
Yield0.00%
5y Average ReturnN/A
Holdings Turnover11.32%
Last DividendN/A
Average for CategoryN/A
Inception DateJan 29, 2020
  • We're sorry we weren't able to find anything about this topic.